FREDERICK, Md., May 20, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® ("TOMI") (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced that TOMI will attend the INTERPHEX 2022 Technical Conference, which takes place Tuesday, May 24 through Thursday, May 26 at the Javits Center in New York City. At the conference, TOMI will have its three main SteraMist mobile units, the Environment System, the Surface Unit, and the SteraPak, on display and available for demonstration.
INTERPHEX is designed to host and connect state-of-the-art market leaders in the pharmaceutical, biotechnology, and life sciences industries. TOMI thrives in this marketplace due to SteraMist iHP technology offering quick, six-log kill decontamination with impressive material compatibility that provides unique advantages over competitors.
Throughout INTERPHEX, TOMI will be meeting with premier customers as well as many prospective clients that have either submitted or requested proposals for the Custom Engineered System (CES) and mobile equipment.
Elissa (E.J.) Shane, Chief Operating Officer at TOMI Environmental Solutions, commented, "TOMI looks forward to INTERPHEX every year as it is a chance for us to connect with current and prospective customers and reconvene with other leaders in the industry to fully demonstrate how SteraMist technology functions."
TOMItm Environmental Solutions, Inc.: Innovating for a safer world®
TOMItm Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BITtm) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BITtm solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHPtm). Represented by the SteraMist® brand of products, iHPtm produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management's judgment, beliefs, current trends, and anticipated product performance. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, the impact of COVID-19 pandemic on our business and customers; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today's date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT
John Nesbett/Jennifer Belodeau
IMS Investor Relations
These press releases may also interest you